CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma
BMC Cancer Mar 14, 2018
Schluter A, et al. - This inquiry was set up to investigate if the number of microvessels and the expression level of vascular endothelial growth factor (VEGF) in the primary tumor are correlated with the degree of lymph node metastasis (N-stage), tumor staging (T) and survival time in patients with squamous cell carcinoma of the larynx (LSCC). A high expression of angiogenic biomarkers was found to be related to reduced survival and an increased rate of recurrence only in the early stage subgroup. Therefore, biomarkers of angiogenesis may be useful to identify high risk patients specifically in early stage LSCC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries